We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Merck to Buy Cubist for $9.5 Billion to Expand Antibiotic Portfolio
Merck to Buy Cubist for $9.5 Billion to Expand Antibiotic Portfolio
December 8, 2014
Merck will buy antibiotic maker Cubist for $9.5 billion as part of a move to develop products that target drug-resistant infections.